Showing results (471-480 of 2,814) with videos related to

Sort By:
Pageof 282
Diabetes Technology & Therapeutics|December 31, 2014
Accuracy of blood glucose meters for self-monitoring affects glucose control and hypoglycemia rate in children and adolescents with type 1 diabetesClaudia Boettcher, Axel Dost, Stefan A Wudy, et al.
Diabetes Technology & Therapeutics|December 6, 2014
Continuous subcutaneous insulin infusion in Italy: third national surveyDaniela Bruttomesso, Luigi Laviola, Giuseppe Lepore, et al.
Diabetes Technology & Therapeutics|December 23, 2014
Evaluation of the long-term durability and glycemic control of fasting plasma glucose and glycosylated hemoglobin for pioglitazone in Japanese patients with type 2 diabetesFrances Stringer, Joost DeJongh, Kazuaki Enya, et al.
Diabetes Technology & Therapeutics|November 5, 2014
Efficacy and safety of metformin for patients with type 1 diabetes mellitus: a meta-analysisCong Liu, Dan Wu, Xuan Zheng, et al.
Diabetes Technology & Therapeutics|November 7, 2014
Gastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysisFeng Sun, Sanbao Chai, Kai Yu, et al.
Diabetes Technology & Therapeutics|November 7, 2014
Relationship of diabetic retinopathy with coronary artery disease in Asian Indians with type 2 diabetes: the Chennai Urban Rural Epidemiology Study (CURES) Eye Study--3Rajendra Pradeepa, Jayagopi Surendar, Karunakaran Indulekha, et al.
Diabetes Technology & Therapeutics|November 20, 2020
Closed-Loop Insulin Therapy Improves Glycemic Control in Adolescents and Young Adults: Outcomes from the International Diabetes Closed-Loop TrialElvira Isganaitis, Dan Raghinaru, Louise Ambler-Osborn, et al.
Diabetes Technology & Therapeutics|November 6, 2020
Clinical Management and Pump Parameter Adjustment of the Control-IQ Closed-Loop Control System: Results from a 6-Month, Multicenter, Randomized Clinical TrialGrenye O'Malley, Laurel H Messer, Carol J Levy, et al.
Diabetes Technology & Therapeutics|September 9, 2020
Proceedings of the Guideline Workshop 2019: Strategies for the Optimization of Guideline Processes in Diabetes, Cardiovascular Diseases, and Kidney DiseasesNikolaus Marx, Lars Rydén, Frank Brosius, et al.
Diabetes Technology & Therapeutics|February 19, 2020
Safety, Immunogenicity, and Glycemic Control of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart in People with Diabetes Also Using Insulin Glargine: 12-Month Results from the GEMELLI 1 TrialSatish K Garg, Karin Wernicke-Panten, Marek Wardecki, et al.
Pageof 282